Navigation Links
Progen Shareholders Call Meeting to Spill Progen Board and Offer Merger or Full Cash Back to Shareholders
Date:1/28/2009

well qualified and experienced directors, Mr. Robert Collins, Dr. Damian Pethica and Mr. Tom Williams, are proposed for appointment to the board of Progen. These candidates bring a strong mix of commercial and scientific skills necessary to drive corporate results for Progen and are strongly supportive of a merger between Progen and Cytopia. Biographies of each candidate are also appended to this announcement.

To avoid any conflict of interest no Cytopia representative has been nominated to the board. The candidates will be obliged to act in the best interests of Progen and the remaining Progen shareholders and their intentions will have been openly communicated to all parties. This will allow for a fully informed decision to be taken by Progen shareholders at the meeting.

"We believe that Cytopia would make an excellent partner for Progen and together we can build a bluechip oncology drug development company with a broad and advanced portfolio of programs," said Mr. Andrew Macdonald, CEO of Cytopia. "For those Progen shareholders who remain committed to this vision our merger proposal is based upon an excellent fit of complementary skills and programs in small molecule biotechnology. There is considerable opportunity to unlock value in both stocks.

"Cytopia is a world class drug development company with drug candidates ranging from the JAK3 program partnered with global pharmaceutical company Novartis through to CYT997, a vascular disrupting agent which is now in Phase II clinical studies. Our business strategy of supporting multiple drug programs and partnering prior to long and expensive Phase III clinical studies is a very commercial strategy.

"Today's actions by the requisitioning Progen shareholders are actually very consistent with the Beerworth and Partners Ltd report recommendations communicated by Progen."

Mr. Macdonald said, "Progen was once a strong player in the Aust
'/>"/>

SOURCE Cytopia Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Progen Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference
2. Progeniq Joins Microsoft in Bio IT Alliance
3. Empire Genomics and Reprogenetics Join Forces to Improve Preimplantation Genetic Diagnosis (PGD)
4. Progentix Orthobiology B.V. Closes Series A Financing Round
5. Progen Expands Drug Development Pipeline Through Acquisition of CellGate
6. Progen Expands Board of Directors
7. Progen Restructures Manufacturing and Drug Discovery Divisions
8. Core Informatics Completes Successful LIMS Implementation for Progenics Pharmaceuticals
9. Wyeth and Progenics Receive Positive Opinion From European Committee for RELISTOR for the Treatment of Opioid-Induced Constipation in Advanced-Illness Patients
10. Progenitor Cell Therapy Secures Industry Accreditation
11. Red Herring Awards ProGenTech Limited for the 2008 Red Herring Asia 100
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Tenn. , July 6, 2015 /PRNewswire/ ... entered into a definitive agreement to acquire ... and intervention platforms that combine data aggregation ... reporting capabilities to achieve actionable insights and ... will combine Altegra Health,s risk adjustment and ...
(Date:7/6/2015)... ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE MKT: IMUC) ... Novella Clinical (Novella), to conduct the phase 3 ... glioblastoma. Novella is a full-service, global clinical research organization ... oncology companies. The ICT-107 phase 3 trial will include ... Europe and Canada , ...
(Date:7/3/2015)... , ... July 03, 2015 , ... The global failure ... 7.52% from 2015 to 2020. The bioscience market is expected to grow at the ... use of failure analysis equipment in the research labs and academic institutions for root ...
(Date:7/2/2015)... ... ... have been used in countless labs for decades. In the past, people had to ... expected, this was a daunting and tiring process looking at endless data tables and charts. ... navigate the complex catalog structure. , Now thanks to FireflySci, scientists are throwing away those ...
Breaking Biology Technology:Emdeon to Acquire Altegra Health 2Emdeon to Acquire Altegra Health 3Emdeon to Acquire Altegra Health 4ImmunoCellular Therapeutics Establishes Agreement with Novella Clinical to Conduct ICT-107 Phase 3 Registration Trial in Glioblastoma 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5New Cuvette E-Commerce Website Launched by FireflySci 2
... Years Recognizes Breakthrough ... of Heart Disease, ABBOTT PARK, Ill., Oct. 28 ... Innovation Award for its XIENCE V(TM),Everolimus Eluting Coronary Stent ... data, the next-generation drug eluting stent,represents a significant advance ...
... Oct. 28 Volcano Corporation,(Nasdaq: VOLC ), a ... the diagnosis and treatment of coronary and peripheral artery,disease, ... for the,third quarter and first nine months of fiscal ... a conference call to discuss its financial,results and operating ...
... 28 Sirnaomics, Inc., (http://www.sirnaomics.com ) announced ... SBIR,(small business innovation research) grant from National ... Sirnaomics, Inc., a,biopharmaceutical company founded in early ... Technology for novel targeted therapeutic,development. The company,s ...
Cached Biology Technology:Abbott's XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award 2Abbott's XIENCE V(TM) Drug Eluting Stent Wins Prestigious Chicago Innovation Award 3Volcano Corporation Schedules Third Quarter Conference Call, Webcast 2Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics 2Sirnaomics Receives SBIR Grant from NCI For Its Multi-Targeted Cancer siRNA Therapeutics 3
(Date:6/18/2015)... YORK , June 18, 2015 This ... US$ Million by the following Product Segments, which includes ... Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric ... the US, Canada , ... Asia-Pacific , Latin America ...
(Date:6/17/2015)... Germany , June 17, 2015 ... Standard: QIA) today launched new Investigator ® STR assay ... the United States . The new genetic ... key genomic markers (short tandem repeats or STRs) for DNA ... evaluate the quality of DNA in each sample, a novel ...
(Date:6/16/2015)... June 16, 2015 /CNW Telbec/ - handyem Inc. ... around the incorporation of handyem,s HPC-150 portable flow ... the Mo-POD™. This unprecedented model of mobile laboratory ... at the Pennsylvania Convention ... 15 th to 18 th 2015. ...
Breaking Biology News(10 mins):Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 2QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 3QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 4QIAGEN Launches New Genetic Fingerprinting Kits for U.S. Forensic Labs 5handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3
... precise biomolecular structures at extremely small scales is critical to ... Traditionally, one of the ways this has been accomplished has ... similar to those used by children in play, but ... molecular "inks" and then stamped onto substrate surfaces, creating a ...
... in Spanish . Tried-and-true techniques could ... conducted by U.S. Department of Agriculture (USDA) scientists. ... has been used as a rapid and nondestructive method for ... Agricultural Research Service (ARS) research leader Dan Long is studying ...
... bumblebees for the first time to see how they select ... return to their nest. In a paper published in ... with the Harmonic Radar Group at Rothamsted Research, were able ... learn their location and use trial and error to find ...
Cached Biology News:Researchers develop new 'stamping' process to pattern biomolecules at high resolution 2New uses for old tools could boost biodiesel output 2How bumblebees find efficient routes without a GPS 2
Protein Kinase D2 Immunogen: Human protein kinase D2. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Request Info...
Immunogen: Recombinant rabbit tryptophan hydroxylase, isolated as inclusion bodies from E. coli and purified by preparative SDS-PAGE. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Inquire...
Biology Products: